Robert DeLong

Title: Innovations of Robert DeLong

Introduction

Robert DeLong is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work has the potential to impact therapeutic methods, including gene therapy and immunization.

Latest Patents

Robert DeLong holds 1 patent for his invention titled "Nucleic acid coated particles suitable for temporary storage." This patent describes particles that are suitable for delivery from a particle-mediated delivery device. The particles are created by precipitating a nucleic acid on inert metal carrier particles in the presence of a nucleic acid condensing agent and a metal ion chelating agent. The patent also outlines processes for preparing these particles and therapeutic methods that utilize them.

Career Highlights

DeLong's career has been marked by his dedication to advancing the field of biotechnology. He works at Powderject Research Limited, where he continues to explore innovative solutions for nucleic acid delivery. His research has the potential to enhance the effectiveness of gene therapy and immunization techniques.

Collaborations

Robert DeLong collaborates with Chris Robert Lively, contributing to the advancement of their shared research interests. Their partnership exemplifies the importance of teamwork in the field of innovation.

Conclusion

Robert DeLong's work in developing nucleic acid coated particles represents a significant advancement in biotechnology. His contributions have the potential to lead to breakthroughs in therapeutic methods, showcasing the importance of innovation in improving healthcare solutions.